Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study Assessing the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Head & Neck Cancers

NCT07072325 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07072325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07072325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study Assessing the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Head & Neck Cancers
Lead sponsor
West China Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 10, 2025
Completion date
August 31, 2028
Enrollment
9 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced head and neck carcinoma, head & neck cancer, head and neck cancer, malignant neoplasm